BE776873A - Composition pharmaceutique destinee a l'evaluation de la secretion biliaire d'organismes animaux - Google Patents

Composition pharmaceutique destinee a l'evaluation de la secretion biliaire d'organismes animaux

Info

Publication number
BE776873A
BE776873A BE776873A BE776873A BE776873A BE 776873 A BE776873 A BE 776873A BE 776873 A BE776873 A BE 776873A BE 776873 A BE776873 A BE 776873A BE 776873 A BE776873 A BE 776873A
Authority
BE
Belgium
Prior art keywords
evaluation
pharmaceutical composition
composition intended
animal organisms
biliary secretion
Prior art date
Application number
BE776873A
Other languages
English (en)
Inventor
A R Imondi
Original Assignee
Rohm & Haas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm & Haas filed Critical Rohm & Haas
Publication of BE776873A publication Critical patent/BE776873A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BE776873A 1970-12-18 1971-12-17 Composition pharmaceutique destinee a l'evaluation de la secretion biliaire d'organismes animaux BE776873A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00099714A US3806592A (en) 1970-12-18 1970-12-18 Method for evaluating bile sufficiency

Publications (1)

Publication Number Publication Date
BE776873A true BE776873A (fr) 1972-06-19

Family

ID=22276276

Family Applications (1)

Application Number Title Priority Date Filing Date
BE776873A BE776873A (fr) 1970-12-18 1971-12-17 Composition pharmaceutique destinee a l'evaluation de la secretion biliaire d'organismes animaux

Country Status (7)

Country Link
US (1) US3806592A (fr)
BE (1) BE776873A (fr)
CA (1) CA984750A (fr)
DE (1) DE2162745A1 (fr)
FR (1) FR2118178B1 (fr)
GB (1) GB1382240A (fr)
NL (1) NL7117216A (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795418A (fr) * 1972-05-24 1973-08-14 Rohm & Haas Procede d'acylation directe des acides aminobenzoiques
AU8107991A (en) * 1990-07-19 1992-02-18 Charwell Pharmaceuticals Limited Diagnostic compositions for assessment of pancreatic insufficiency
GB2251381B (en) * 1990-07-19 1995-01-25 Charwell Pharma Emulsified fluorescein diester diagnostic compositions
US5506147A (en) * 1993-04-15 1996-04-09 Kolhouse; J. Fred Non-invasive evaluation of maldigestion and malaborption
US6159445A (en) * 1994-07-20 2000-12-12 Nycomed Imaging As Light imaging contrast agents
US6540981B2 (en) 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
GB9502065D0 (en) * 1995-02-02 1995-03-22 Nycomed Imaging As Contrast media
AU2483600A (en) * 1998-12-21 2000-07-12 Sequella, Inc. Methods and compositions comprising monitoring devices
WO2018026538A1 (fr) * 2016-08-02 2018-02-08 ISI Life Sciences Inc. Nouveaux échafaudages pour l'administration intracellulaire de composés pour la détection de cellules cancéreuses.
EP3493855A4 (fr) * 2016-08-02 2020-04-01 ISI Life Sciences, Inc. Méthode de détection de cellules cancéreuses.
US10239891B2 (en) 2017-05-15 2019-03-26 Indicator Systems International, Inc. Compositions to detect remnant cancer cells
US10753942B2 (en) 2017-05-15 2020-08-25 Indicator Systems International, Inc. Methods to detect remnant cancer cells

Also Published As

Publication number Publication date
FR2118178B1 (fr) 1975-08-01
NL7117216A (fr) 1972-06-20
FR2118178A1 (fr) 1972-07-28
CA984750A (en) 1976-03-02
DE2162745A1 (de) 1972-06-22
GB1382240A (en) 1975-01-29
US3806592A (en) 1974-04-23

Similar Documents

Publication Publication Date Title
BE794946A (fr) Nouvelles compositions d'esters
CH541324A (fr) Matière d'implant corporel
BE774161A (fr) Procede et composition s'opposant a la
BE768269A (fr) Composition pharmaceutique
RO62745A (fr) Composition pour elimination des dechets a voie biologique
BE776873A (fr) Composition pharmaceutique destinee a l'evaluation de la secretion biliaire d'organismes animaux
BE808603A (fr) Mecanisme d'entrainement en va-et-vient
BE796359A (fr) Composition d'oeuf synthetique
BE771473A (fr) Agent d'ignifugation de matieres synthetiques et procede pour sa preparation
BE794517A (fr) Herbicide pour l'agriculture
BE811489A (fr) Phenoxyalcanecarboxylates d'hydroxyalkyltheophyllines
CH544486A (fr) Cage pour l'élevage d'animaux
BE775640A (fr) Composition pharmaceutique
BG20371A3 (bg) Метод за получаване на n-бензхидрил-n'-р- хидробензил-пиперазини
OA03710A (fr) Composition d'engrais.
BE801759A (fr) Palier d'extremite de tringle
BE808591A (fr) Derives d'acide amidomethane-phosphonique
BE802719A (fr) Derives de l'acide 9-hydroxy-13-trans-prostenoique
BE776768A (fr) Composition pharmaceutique
BE795744A (fr) Compositions retardatrices d'inflammation
FR2100950A1 (fr) Composition pharmaceutique
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
BE786128A (fr) Compositions effervescentes contenant l'ester methylique de l-aspartyl-l-3-phenylalanine
CH512765A (fr) Mécanisme d'entraînement d'un indicateur de quantième et/ou de jours de la semaine
BE802539A (fr) Derives d'acides phenoxy-alicycliques-carboxyliques